Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TEM
TEM logo

TEM News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

TEM News

Tempus and Predicta Launch Co-Branded Genomic Sequencing Assay

6d agoNewsfilter

Tempus AI Announces 31 Abstracts for AACR Annual Meeting 2026

Apr 14 2026Newsfilter

Latest Wall Street Ratings Overview

Apr 13 2026CNBC

Tempus Launches Automated Clinical Update Service for Precision Medicine

Apr 13 2026Newsfilter

Tempus Expands Collaboration with Gilead to Enhance Oncology Pipeline

Apr 09 2026Newsfilter

TEMPUS FORGES STRATEGIC PARTNERSHIP WITH GILEAD TO ENHANCE ONCOLOGY RESEARCH AND DEVELOPMENT USING REAL-WORLD EVIDENCE

Apr 09 2026moomoo

AI's Promising Applications in Healthcare

Mar 31 2026Fool

Cathie Wood Shifts AI Investment Focus to Healthcare

Mar 30 2026Newsfilter

TEM Events

04/15 16:30
Major Averages Close Mixed as Bank of America and Morgan Stanley Beat Q1 Earnings
The major averages closed mixed as traders remain optimistic about a possible end to the U.S.-Iran war, particularly amid renewed signals that a new round of talks could resume within days as well as tentative reports of a ceasefire extension. This has kept oil capped below the recent highs and prevented another spike in inflation expectations, even though the broader conflict remains unresolved.Meanwhile, investors are weighing corporate earnings, with major lenders Bank of America and Morgan Stanley leading the way with Q1 beats.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Bank of Americaprovided areport for Q1Morgan Stanleyreported, with the company saying it is entering 2026 from a position of strengthBroadcomand Metaannounced an expanded partnership overBRPfollowing the recent amendment of Section 232 tariffs on steel, aluminum and copper imports into the U.S.ASMLreported ain Q1 earnings and revenue2. WALL STREET CALLS:Cloudflareto Overweight at Piper SandlerSolarEdgeto Sell at Goldman Sachs on challenging valuationCitiAdientto Buy, opened "90-day upside catalyst watch"Shift4 Paymentsto Peer Perform at Wolfe ResearchDA DavidsonSymboticto Buy on "unparalleled" AI tech moat3. AROUND THE WEB:A jury has found that Live Nationmonopolized the ticketing market, Bloomberg reportsSazerac offered to acquire Brown-Formanfor $32 per share, WSJ reportsAMD, Arm, and Qualcommare investing $60M in Wayve as an extension of its $1.2B Series D round, TechCrunch reportsStellantismulls carmaking deal with Dongfengin Europe, China, Bloomberg saysAnthropic has fielded multiple offers from VCs valuing the company at as much as $800B in recent weeks, Business Insider says4. MOVERS:Oklowas higher after announcingWebullgained after theto remove day-trading limit for investorsTempus AIincreased after announcing an expansion of itsTeraWulfwas lower afterDauchfell after TD Cowenits price target to $7 from $85. EARNINGS/GUIDANCE:Orionbacked itsM&T Bank, with Daryl Bible, M&T's CFO commenting, "M&T continued to produce strong operating results and return capital to its shareholders in the recent quarter"NOV Inc.and earnings guidance below prior guidanceSnapprovidedGloo, backed its guidance for Q1, and raised its outlook for FY26INDEXES:The Dow fell 72.27, or 0.15%, to 48,463.72, the Nasdaq gained 376.93, or 1.59%, to 24,016.02, and the S&P 500 advanced 55.57, or 0.80%, to 7,022.95.
04/15 12:00
Dow Jones Falls, S&P 500 and Nasdaq Rise
The major averages were mixed near noon, with the Dow Jones Industrial Average in the red and the S&P 500 and Nasdaq trading higher. Traders remain optimistic about a possible end to the U.S.-Iran war, particularly amid renewed signals that a new round of talks could resume within days as well as tentative reports of a ceasefire extension. This has kept oil capped below the recent highs and prevented another spike in inflation expectations, even though the broader conflict remains unresolved.Meanwhile, investors are weighing a new slate of corporate earnings, with major lenders Bank of America and Morgan Stanley leading the way with Q1 beats.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Bank of Americaprovided areport for Q1Morgan Stanleyreported, with the company saying it is entering 2026 from a position of strengthBroadcomand Metaannounced an expanded partnership overBRPfollowing the recent amendment of Section 232 tariffs on steel, aluminum and copper imports into the U.S.ASMLreported a year-over-year increase in2. WALL STREET CALLS:Cloudflareto Overweight at Piper SandlerSolarEdgeto Sell at Goldman Sachs on challenging valuationCitiAdientto Buy, opened "90-day upside catalyst watch"Shift4 Paymentsto Peer Perform at Wolfe ResearchDA DavidsonSymboticto Buy on "unparalleled" AI tech moat3. AROUND THE WEB:AMD, Arm, and Qualcommare investing $60M in Wayve as an extension of its $1.2B Series D round, TechCrunch reportsVolkswagenis preparing for even tougher competition in China, where the car market could shrink for the first time in a decade, Reuters reportsStellantismulls carmaking deal with Dongfengin Europe, China, Bloomberg saysUberCTO Praveen Neppalli Naga says the company's surging use of AI coding tools has maxed out its full-year AI budget just a few months into 2026, The Information reportsAnthropic has fielded multiple offers from VCs valuing the company at as much as $800B in recent weeks, Business Insider says4. MOVERS:Oklohigher afterto its board of directorsWebullgains after theto remove day-trading limit for investorsTempus AIincreases afterof its GenoPredicta with Predicta BiosciencesTeraWulflower after announcing aDauchfalls after TD Cowento $7 from $85. EARNINGS/GUIDANCE:Orionfor FY26 and FY27M&T Bank, with Daryl Bible, M&T's CFO commenting, "M&T continued to produce strong operating results and return capital to its shareholders in the recent quarter"NOV Inc.and earnings guidance below prior guidanceSnapGloo, backed its guidance for Q1, and raised its outlook for FY26INDEXES:Near midday, the Dow was down 0.40%, or 192.72, to 48,343.27, the Nasdaq was up 1.06%, or 250.76, to 23,889.84, and the S&P 500 was up 0.45%, or 31.46, to 6,998.84.
04/15 08:40
Tempus AI and Predicta Biosciences Expand GenoPredicta Commercial Partnership
Tempus AI and Predicta Biosciences announced the commercial expansion of a co-branded whole-genome sequencing, WGS, assay, currently known as GenoPredicta, intended for the comprehensive genomic characterization of hematologic malignancies and measurable residual disease, MRD, monitoring. "GenoPredicta offers a novel, unified solution for our life science partners and a comprehensive replacement for traditional, siloed testing," said Kate Sasser, PhD, Chief Scientific Officer at Tempus. "By consolidating flow cytometry, cytogenetics, and WGS into one ultrasensitive workflow, we can identify high-risk biomarkers and track clonal evolution from as few as 50 tumor cells. Crucially, because the assay delivers 100% concordance between peripheral blood and bone marrow, it can provide these deep insights while sparing patients from biopsies."

TEM Monitor News

Tempus AI and Predicta Launch GenoPredicta Genomic Sequencing Assay

Apr 15 2026

Tempus AI Expands Collaboration with Gilead to Enhance Oncology Research

Apr 14 2026

Tempus AI Expands Collaboration with Gilead to Enhance Oncology Research

Apr 13 2026

Tempus AI Expands Collaboration with Gilead for Oncology Research

Apr 09 2026

Tempus AI Stock Rises Following Partnership with Daiichi Sankyo

Mar 31 2026

Tempus AI stock declines amid market weakness and ARK's cautious sentiment

Mar 27 2026

Tempus AI stock declines after hitting a 20-day low amid market weakness

Mar 26 2026

Tempus AI stock declines after crossing below 5-day SMA

Mar 25 2026

TEM Earnings Analysis

No Data

No Data

People Also Watch